ROCC Knee Data Collection
Sponsor
Zimmer Biomet (Industry)
Overall Status
Terminated
CT.gov ID
NCT00758901
Collaborator
Biomet France SARL (Industry)
200
3
85
66.7
0.8
Study Details
Study Description
Brief Summary
This observational study intends to collect efficacy and safety data on ROCC Knee system.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
The ROCC® prosthesis is a rotating platform with:
-
Highly congruent surface contact,
-
NON CONSTRAINED kinematics allowing posterior roll back until 110° then anterior in hyperflexion like a normal knee
-
Allowing asymmetric movement
Study Design
Study Type:
Observational
Actual Enrollment
:
200 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
A Prospective, Multicentre Study Evaluating the Clinical Performance of the ROCC Knee Prosthesis
Study Start Date
:
Nov 1, 2003
Actual Primary Completion Date
:
Dec 1, 2010
Actual Study Completion Date
:
Dec 1, 2010
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
1 ROCC Knee prosthesis Consecutive series of patients with ROCC Knee prosthesis. |
Device: Knee Replacement (with ROCC Knee prosthesis)
Knee Replacement (with ROCC Knee prosthesis)
Other Names:
|
Outcome Measures
Primary Outcome Measures
- American Knee Score [3 months, 1yr, 2yr, 3yr, 4yr and 5 yr]
Secondary Outcome Measures
- Complication [Any time]
- Patient Satisfaction [3 months, 1yr, 2yr, 3yr, 4yr and 5 yr]
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Patients suitable for Knee Replacement for:
-
osteoarthritis,
-
rheumatoid arthritis
-
bone necrosis affecting two knee compartments,
-
correction of genu varus, genu valgus or post-traumatic deformities,
-
sequelae of prior procedures.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | A. ö Landeskrankenhaus Gmunden | Gmunden | Austria | ||
2 | Clinique des Fontaines | Meulin | France | ||
3 | Hospital Torrecardenas | Almeria | Spain |
Sponsors and Collaborators
- Zimmer Biomet
- Biomet France SARL
Investigators
- Principal Investigator: Michel BERCOVY, MD, Clinique des Fontaines
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Zimmer Biomet
ClinicalTrials.gov Identifier:
NCT00758901
Other Study ID Numbers:
- BMET FR 03
First Posted:
Sep 25, 2008
Last Update Posted:
Mar 10, 2017
Last Verified:
Mar 1, 2017
Additional relevant MeSH terms: